Bally’s Corporation (NYSE: BALY) eyes evoke plc (LSE: EVOK): why a William Hill deal would reshape UK gambling
Read More Pharma Industry News Why Immunome’s Phase 3 varegacestat data could reshape the desmoid tumor treatment market Immunome is set to release Phase 3 varegacestat data that could redefine its oncology strategy and valuation. Read what this catalyst really means. byPallavi MadhirajuDecember 15, 2025